(S)-2-((tert-Butoxycarbonyl)amino)-2,3-dimethylbutanoic acid, 95.0%, 100mg

Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-[[(4S)-4-hydroxy-4-methyl-2-isoxazolidinyl]carbonyl]-3-methyl-1-(1-methylethyl)-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-, 50mg

Ethyl 3-bromo-5-nitrobenzoate, 95.0%, 10g

NN'-Bis(2-hydroxyethyl)urea, 97%, 250mg

METHYL 5-BROMO-3-HYDROXY-2-METHYLBENZOATE, 95%, 25g

1,6-Hexanediol, >=96%, para síntesis, 250 g, envase plástico.

1-[(4-bromophenyl)methyl]-1,4-diazepane, 95.0%, 1g

N,N'-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,7-diyl)diacetamide, 98%, 100mg

4,5'-Dimethyl-[2,2']bipyridinyl, 97.0%, 2g

Methyl 5-fluoro-6-methoxynicotinate, 95.0%, 1g

Methyl 2-(7-hydroxy-4-methyl-2-oxo-2h-chromen-3-yl)acetate, 95%, 1g

Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 97.0%, 1g

TRANS-6-METHYL-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER 3-METHYL ESTER, 95.0%, 1g